CXCL12 and neoplasm: Some studies have shown that high expression of SDF-1 in cancer cells attracts CXCR4-positive cells, such as cancer-associated fibroblasts (CAFs) or tumor infiltrating lymphocytes (TILs), to the tumor sites and converts the tumor microenvironment (TME) to immune tolerance (12–14).